What changed
Chairman Dr. Ahmed Jamaloodeen reported direct beneficial ownership of 831,301,460 TXTM common shares as of October 6, 2026, up 55,646,456 shares from 775,655,004 reported on May 20, 2026. The shares were accumulated without converting any preferred securities, and management confirmed zero preferred-share conversions by both the Chairman and CEO Dylon Du Plooy. Dr. Jamaloodeen has never sold any TXTM common shares. The company cited institutional readiness, IFRS financial reporting, real-world asset infrastructure and regulated-exchange objectives.
Why it matters
Chairman Dr. Ahmed Jamaloodeen reported direct beneficial ownership of 831,301,460 TXTM common shares as of October 6, 2026, up 55,646,456 shares from 775,655,004 reported on May 20, 2026. The shares